Secure your place at the Digiday Media Buying Summit in Nashville, March 2-4
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
WTF are tokens?
When someone sends a prompt or receives a response, the system breaks language into small segments. These fragments are tokens.
AI is changing how retailers select tech partners
The quick rise of artificial intelligence-powered tools has reshaped retailers’ process of selecting technology partners for anything from marketing to supply chain to merchandising.
YouTube’s upmarket TV push still runs on mid-funnel DNA
YouTube is balancing wanting to be premium TV, the short-form powerhouse and a creator economy engine all at once.